School of Medical Sciences,
Faculty of Medicine,
School of Medical Sciences, Faculty of Medicine
Philip J. Barter has not added Biography.
If you are Philip J. Barter and would like to personalize this page please email our Author Liaison for assistance.
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.
Current opinion in lipidology Jun, 2002 | Pubmed ID: 12045398
Coronary plaque regression: role of low density lipoprotein-apheresis.
Journal of the American College of Cardiology Jul, 2002 | Pubmed ID: 12106924
Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
Biochemistry Oct, 2002 | Pubmed ID: 12369845
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2002 | Pubmed ID: 12426224
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology Feb, 2003 | Pubmed ID: 12588754
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
The Journal of biological chemistry Jun, 2003 | Pubmed ID: 12690114
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
Arteriosclerosis, thrombosis, and vascular biology Mar, 2004 | Pubmed ID: 14592845
Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
Biochemistry Nov, 2003 | Pubmed ID: 14622025
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
American heart journal Apr, 2004 | Pubmed ID: 15077101
High-density lipoproteins neutralize C-reactive protein proinflammatory activity.
Circulation May, 2004 | Pubmed ID: 15078800
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner.
Biochemistry Sep, 2004 | Pubmed ID: 15379569
Antiinflammatory properties of HDL.
Circulation research Oct, 2004 | Pubmed ID: 15486323
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
The American journal of cardiology Jan, 2005 | Pubmed ID: 15642551
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.
Circulation Mar, 2005 | Pubmed ID: 15781735
High-density lipoproteins as therapeutic targets.
Current opinion in lipidology Jun, 2005 | Pubmed ID: 15891397
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
Journal of lipid research Oct, 2005 | Pubmed ID: 16061952
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2005 | Pubmed ID: 16141405
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.
Journal of lipid research Jan, 2006 | Pubmed ID: 16222033
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
Journal of lipid research May, 2006 | Pubmed ID: 16452453
Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
Journal of the American College of Cardiology Feb, 2006 | Pubmed ID: 16458126
High-density lipoproteins enhance progenitor-mediated endothelium repair in mice.
Arteriosclerosis, thrombosis, and vascular biology May, 2006 | Pubmed ID: 16528007
Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
Circulation Mar, 2006 | Pubmed ID: 16567579
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
Current opinion in lipidology Aug, 2006 | Pubmed ID: 16832163
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function.
Journal of the American College of Cardiology Aug, 2006 | Pubmed ID: 16904539
Homocysteine and cardiovascular disease: is HDL the link?
Circulation research Sep, 2006 | Pubmed ID: 16973911
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
Circulation Sep, 2006 | Pubmed ID: 16982953
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
The New England journal of medicine Apr, 2007 | Pubmed ID: 17387131
N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins.
Journal of lipid research Sep, 2007 | Pubmed ID: 17545692
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo.
Atherosclerosis Jan, 2008 | Pubmed ID: 17586510
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?
Arteriosclerosis, thrombosis, and vascular biology Jan, 2008 | Pubmed ID: 17717290
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.
Atherosclerosis Feb, 2008 | Pubmed ID: 17765244
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
Journal of lipid research Jan, 2008 | Pubmed ID: 17921435
Effects of torcetrapib in patients at high risk for coronary events.
The New England journal of medicine Nov, 2007 | Pubmed ID: 17984165
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
Current cardiology reports Nov, 2007 | Pubmed ID: 17999875
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.
Clinical chemistry Jun, 2008 | Pubmed ID: 18436719
Antiinflammatory actions of HDL: a new insight.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2008 | Pubmed ID: 18946054
The metabolism and anti-atherogenic properties of HDL.
Journal of lipid research Apr, 2009 | Pubmed ID: 19033213
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.
Atherosclerosis Jun, 2009 | Pubmed ID: 19111829
Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.
Obesity (Silver Spring, Md.) Apr, 2009 | Pubmed ID: 19165155
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate.
Arteriosclerosis, thrombosis, and vascular biology Jun, 2009 | Pubmed ID: 19325138
Cholesterol metabolism and pancreatic beta-cell function.
Current opinion in lipidology Jun, 2009 | Pubmed ID: 19417651
Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts.
Free radical research Aug, 2009 | Pubmed ID: 19521892
Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology Feb, 2010 | Pubmed ID: 19910639
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.
Journal of lipid research Jun, 2010 | Pubmed ID: 19965573
The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
Arteriosclerosis, thrombosis, and vascular biology Feb, 2010 | Pubmed ID: 19965776
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
The American journal of cardiology Jan, 2010 | Pubmed ID: 20102893
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
Arteriosclerosis, thrombosis, and vascular biology Apr, 2010 | Pubmed ID: 20110571
Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids.
Arteriosclerosis, thrombosis, and vascular biology May, 2010 | Pubmed ID: 20167660
Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.
Arteriosclerosis, thrombosis, and vascular biology Aug, 2010 | Pubmed ID: 20466975
Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
Atherosclerosis Oct, 2010 | Pubmed ID: 20609437
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Arteriosclerosis, thrombosis, and vascular biology Sep, 2010 | Pubmed ID: 20702809
The relationship between cholesteryl ester transfer protein and cardiovascular risk.
Clinical chemistry Oct, 2010 | Pubmed ID: 20739636
Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
Arteriosclerosis, thrombosis, and vascular biology May, 2011 | Pubmed ID: 21330603
Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
Cardiovascular research Jul, 2011 | Pubmed ID: 21354994
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Atherosclerosis Aug, 2011 | Pubmed ID: 21571275
The causes and consequences of low levels of high density lipoproteins in patients with diabetes.
Diabetes & metabolism journal Apr, 2011 | Pubmed ID: 21738891
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
Circulation Aug, 2011 | Pubmed ID: 21804130
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008.
Atherosclerosis Dec, 2011 | Pubmed ID: 21840000
Predictive value of different HDL particles for the protection against or risk of coronary heart disease.
Biochimica et biophysica acta Mar, 2012 | Pubmed ID: 22051746
Effect of two intensive statin regimens on progression of coronary disease.
The New England journal of medicine Dec, 2011 | Pubmed ID: 22085316
Niacin inhibits vascular inflammation via the induction of heme oxygenase-1.
Circulation Jan, 2012 | Pubmed ID: 22095827
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.
Lipids in health and disease , 2011 | Pubmed ID: 22128776
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.
Cardiovascular drugs and therapy Apr, 2012 | Pubmed ID: 22349989
The inhibition of cholesteryl ester transfer protein: a long and winding road.
Journal of lipid research Jun, 2012 | Pubmed ID: 22496386
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.
Journal of lipid research Sep, 2012 | Pubmed ID: 22550134
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study.
Journal of the American College of Cardiology May, 2012 | Pubmed ID: 22575316
Relationship between atorvastatin dose and the harm caused by torcetrapib.
Journal of lipid research Nov, 2012 | Pubmed ID: 22941786
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
Circulation research Jan, 2013 | Pubmed ID: 23123430
Effects of dalcetrapib in patients with a recent acute coronary syndrome.
The New England journal of medicine Nov, 2012 | Pubmed ID: 23126252
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
The Journal of clinical endocrinology and metabolism Dec, 2012 | Pubmed ID: 23144467
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008.
Annals of epidemiology Feb, 2013 | Pubmed ID: 23218811
Dalcetrapib in patients with an acute coronary syndrome.
The New England journal of medicine Feb, 2013 | Pubmed ID: 23445098
The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER.
European heart journal May, 2013 | Pubmed ID: 23482520
Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER.
Atherosclerosis May, 2013 | Pubmed ID: 23510828
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database.
European journal of preventive cardiology Dec, 2013 | Pubmed ID: 23644489
Trends in C-reactive protein levels in US adults from 1999 to 2010.
American journal of epidemiology Jun, 2013 | Pubmed ID: 23669654
Cardioprotective functions of HDLs.
Journal of lipid research Feb, 2014 | Pubmed ID: 23812558
High-density lipoproteins: a consensus statement from the National Lipid Association.
Journal of clinical lipidology Sep-Oct, 2013 | Pubmed ID: 24079290
High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation.
Journal of lipid research Mar, 2014 | Pubmed ID: 24347528
Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology Mar, 2014 | Pubmed ID: 24357062
Regulation of high-density lipoprotein metabolism.
Circulation research Jan, 2014 | Pubmed ID: 24385508
High density lipoprotein: a therapeutic target in type 2 diabetes.
Endocrinology and metabolism (Seoul, Korea) Sep, 2013 | Pubmed ID: 24396675
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.
Nature communications Feb, 2014 | Pubmed ID: 24576947
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
Journal of the American College of Cardiology Jun, 2014 | Pubmed ID: 24632287
Cardiovascular drugs that increase the risk of new-onset diabetes.
American heart journal Apr, 2014 | Pubmed ID: 24655688
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
The American journal of cardiology May, 2014 | Pubmed ID: 24666618
The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004.
PloS one , 2014 | Pubmed ID: 24728477
The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: the Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis Oct, 2014 | Pubmed ID: 25108074
Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
Arteriosclerosis, thrombosis, and vascular biology Oct, 2014 | Pubmed ID: 25147338
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2014 | Pubmed ID: 25212234
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Diabetologia Mar, 2015 | Pubmed ID: 25425220
Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.
Arteriosclerosis, thrombosis, and vascular biology Mar, 2015 | Pubmed ID: 25633313
Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis Apr, 2015 | Pubmed ID: 25682037
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet (London, England) Aug, 2015 | Pubmed ID: 26047975
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Diabetologia Sep, 2015 | Pubmed ID: 26055067
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
Atherosclerosis Aug, 2015 | Pubmed ID: 26074319
Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis.
Atherosclerosis Aug, 2015 | Pubmed ID: 26117404
Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis.
International journal of cardiology Nov, 2015 | Pubmed ID: 26204569
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case.
Circulation Aug, 2015 | Pubmed ID: 26240263
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis.
European journal of preventive cardiology May, 2016 | Pubmed ID: 26246463
Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis.
Arteriosclerosis, thrombosis, and vascular biology Nov, 2015 | Pubmed ID: 26359513
Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?
Journal of lipid research Nov, 2015 | Pubmed ID: 26378095
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions Feb, 2016 | Pubmed ID: 26385396
Speed kills in more ways than one: Methamphetamine and atherosclerosis.
Atherosclerosis Dec, 2015 | Pubmed ID: 26522439
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?
Clinical therapeutics Dec, 2015 | Pubmed ID: 26548324
Apolipoprotein A-I interactions with insulin secretion and production.
Current opinion in lipidology Feb, 2016 | Pubmed ID: 26655291
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.
American heart journal Dec, 2015 | Pubmed ID: 26678626
Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--Pro.
Arteriosclerosis, thrombosis, and vascular biology Mar, 2016 | Pubmed ID: 26848159
A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo.
Cell & bioscience , 2016 | Pubmed ID: 26855766
High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males.
PloS one , 2016 | Pubmed ID: 26962854
Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jun, 2016 | Pubmed ID: 26965683
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.
The American journal of cardiology May, 2016 | Pubmed ID: 26969416
New Era of Lipid-Lowering Drugs.
Pharmacological reviews Apr, 2016 | Pubmed ID: 26983688
Coronary artery disease: Scavenger receptor class B1--a target to reduce CHD risk?
Nature reviews. Cardiology May, 2016 | Pubmed ID: 27053456
In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
Diabetologia Sep, 2016 | Pubmed ID: 27193916
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
The lancet. Diabetes & endocrinology Oct, 2016 | Pubmed ID: 27246162
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.
European heart journal. Cardiovascular pharmacotherapy Oct, 2016 | Pubmed ID: 27533947
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism.
Diabetes Dec, 2016 | Pubmed ID: 27702832
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.
Journal of the American College of Cardiology Dec, 2016 | Pubmed ID: 27908356
Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620.
Diabetes Feb, 2017 | Pubmed ID: 27908917
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
Journal of the American Heart Association Jan, 2017 | Pubmed ID: 28073769
The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments.
Scientific reports Feb, 2017 | Pubmed ID: 28165022
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados